• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Sunday 12/9/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

QBIO

  • 2:52 PM

    Proceeds To Fund Commercialization of First Approved Drug and Pivotal Clinical Programs in 2018   NEW YORK, January 30, 2018 /PRNewswire/ — Q BioMed Inc. (OTCQB: QBIO) (“Q BioMed” or the “Company”), a commercial stage biotechnology acceleration development company is pleased to announce pricing of a public offering of an aggregate of 1,711,875 shares of common stock of the Company, together with warrants to purchase up to 1,711,875 shares of common stock of the Company, at a public offering price of $3.20 per share

    Read more
  • 2:36 PM

    MIAMI, FL–RXMD, (Marketwired – April 07, 2016) – Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, reports record breaking month of March. The pharmacy broke its all-time sales records during the month of March, filling approximately 18,600

    Read more
  • 3:30 PM

    MIAMI, FL— RXMD, (Marketwired – February 16, 2016) – Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces over $1.3 million in pharmacy revenues for the first month of the year. The pharmacy filled over 15,500 prescriptions

    Read more
  • 4:06 PM

    MIAMI, FL— RXMD, (Marketwired – January 14, 2016) – Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record revenues and prescriptions sales for 2015. The pharmacy filled nearly 180,000 prescriptions in 2015, which is a 28%

    Read more
  • Ani Pharmaceuticals
    4:19 PM

    – NDA #008975 Purified Cortrophin Gel, 40 units/mL and 80 units/mL – NDA #009854 Cortrophin-Zinc hydroxide, 40 units/mL BAUDETTE, Minn., Jan. 5, 2016, ANIP, /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that it has completed the acquisition of the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck (known as MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales. The acquisition was funded through

    Read more
  • 2:51 PM

    Nov 17, 2015 – OTC Disclosure & News Service – MusclePharm Corporation (OTCQB: MSLP) (“MusclePharm” or the “Company”), a scientifically driven, performance-lifestyle sports nutrition company, today announced that it has previously retained an investment banker to explore the sale of all or substantially all of the assets of its BioZone Laboratories Inc. subsidiary. BioZone is a developer, manufacturer, and marketer of over-the-counter drugs and preparations, cosmetics, and nutritional supplements. BioZone also develops novel drug delivery platforms, including its QuSome® technology.

    Read more
Public Wire Banner